Raymond James raises e.l.f. Beauty stock price target on strong results

Raymond James raised its e.l.f. Beauty price target to $132 from $117 and maintained Strong Buy after fiscal Q2 results beat expectations: sales rose 51% year over year, and EPS was $1.21 versus the firm’s $0.65 estimate and $0.60 consensus. The company raised full-year EPS guidance to $3.82–$3.86 from $3.50–$3.55; it expects second-half organic sales growth of 7–10%, with Q3 above and Q4 below that range. The article also reports shares had risen 91% over the prior six months.

Analysis

The key issue is earnings quality, not the size of the beat: reported growth and price/mix were materially influenced by Rhode’s Sephora EU launch, while Rhode is no longer separately disclosed. That makes it harder to distinguish durable core-brand demand from acquired-brand contribution just as comparisons become less favorable. The guided second-half slowdown is therefore a test of underlying velocity, not automatically evidence of demand deterioration; the expected Q3/Q4 cadence also creates asymmetric headline risk if investors anchor on the exceptional quarter.

Near term, the sharp six-month rerating and the cited fair-value proximity leave less room for another forecast beat to translate into multiple expansion. Over 1–3 months, watch organic growth against the company’s range, gross-margin durability, and inventory/promotion signals; a deceleration paired with margin giveback would challenge the quality-of-growth narrative. Over 6–18 months, the structural question is whether e.l.f. can sustain customer acquisition and premiumization across brands without relying on launch-driven mix or retailer expansion.

Contrarian angle: the deceleration may be largely an arithmetic and launch-comparison issue, so a growth slowdown alone is not a short thesis. But the market may be underpricing the loss of visibility created by Rhode’s discontinued breakout. The evidence supplied does not establish a valuation discount or justify a directional short.

Key Decisions for Investors

• Do not chase ELF solely on the quarter or the higher analyst target after the recent rally. For existing longs, consider trimming into strength or keeping exposure sized for a tougher comparison period; no numeric price level is supported by the available data.
• Treat the next 1–3 months as a verification window: track organic growth versus guidance, gross-margin trend, and inventory/promotion commentary. A miss on growth accompanied by margin compression would falsify the thesis that the slowdown is mainly comparison-driven.
• Keep ELF on a pullback watchlist rather than initiating an unhedged short. A defined-risk bullish options position is only worth evaluating if implied volatility and option pricing are attractive; those data are not provided.
• Request brand-level or other channel evidence on Rhode and core e.l.f. demand where available. If management disclosure cannot separate the drivers, increase the required margin of safety before underwriting continued premium growth.